These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11213841)

  • 1. Volume-weighted mean nuclear volume and numerical nuclear density in the cardiomyocyte following enalapril and verapamil treatment.
    Mandarim-de-Lacerda CA; Pereira LM
    Virchows Arch; 2001 Jan; 438(1):92-5. PubMed ID: 11213841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.
    Pereira LM; Mandarim-De-Lacerda CA
    Int J Exp Pathol; 2001 Apr; 82(2):115-22. PubMed ID: 11454102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereology of cardiac hypertrophy induced by NO blockade in rats treated with enalapril and verapamil.
    Pereira LM; Mandarim-de-Lacerda CA
    Anal Quant Cytol Histol; 2001 Oct; 23(5):330-8. PubMed ID: 11693558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antihypertensive drugs on the myocardial microvessels in rats with nitric oxide blockade.
    Meirelles Pereira LM; Mandarim-de-Lacerda CA
    Pathol Res Pract; 2000; 196(5):305-11. PubMed ID: 10834387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cortical remodelling by NO-synthesis blockers in rats is prevented by angiotensin-converting enzyme inhibitor and calcium channel blocker.
    Mandarim-de-Lacerda CA; Pereira LM
    J Cell Mol Med; 2001; 5(3):276-83. PubMed ID: 12067486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aortic wall remodeling in rats with nitric oxide deficiency treated by enalapril or verapamil.
    Pereira LM; Bezerra DG; Mandarim-de-Lacerda CA
    Pathol Res Pract; 2004; 200(3):211-7. PubMed ID: 15200273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart biometry and allometry in rats submitted to nitric oxide synthesis blockade and treatment with antihypertensive drugs.
    Mandarim-de-Lacerda CA; Pereira LM
    Ann Anat; 2001 Mar; 183(2):171-6. PubMed ID: 11325065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney adaptation in nitric oxide-deficient Wistar and spontaneously hypertensive rats.
    Pereira LM; Almeida JR; Mandarim-de-Lacerda CA
    Life Sci; 2004 Jan; 74(11):1375-86. PubMed ID: 14706568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the inhibitory effect of N(G)-nitro-L-arginine methyl ester on the antihypertensive effect of the angiotensin AT1 receptor antagonist, GR138950.
    Anderson IK; Drew GM
    Br J Pharmacol; 1997 Dec; 122(7):1385-94. PubMed ID: 9421286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effect of enalapril in spontaneously hypertensive rats cardiac remodeling with nitric oxide synthesis blockade.
    de Andrade Zorzi RL; Meirelles Pereira LM; Mandarim-de-Lacerda CA
    J Cell Mol Med; 2002; 6(4):599-608. PubMed ID: 12611644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V; Rigamonti A; Fioretti S; Bonomo S; Manfredi B; Ferrario P; Bianchi M; Berti F; Muller EE; Rossoni G
    Eur J Pharmacol; 2005 Jun; 516(3):253-9. PubMed ID: 15963975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal cortex remodeling in nitric oxide deficient rats treated with enalapril.
    Barbuto N; Almeida JR; Pereira LM; Mandarim-de-Lacerda CA
    J Cell Mol Med; 2004; 8(1):102-8. PubMed ID: 15090265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressure natriuresis in nitric oxide-deficient hypertensive rats: effect of antihypertensive treatments.
    Fortepiani LA; Rodrigo E; Ortíz MC; Cachofeiro V; Atucha NM; Ruilope LM; Lahera V; García-Estañ J
    J Am Soc Nephrol; 1999 Jan; 10(1):21-7. PubMed ID: 9890305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against L-NAME-induced reduction in cardiac output persists even after cessation of angiotensin-converting enzyme inhibitor treatment.
    Biwer LA; Broderick TL; Xu H; Carroll C; Hale TM
    Acta Physiol (Oxf); 2013 Jan; 207(1):156-65. PubMed ID: 22834875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basilar artery remodelling in the genetically hypertensive rat: effects of nitric oxide synthase inhibition and treatment with valsartan and enalapril.
    Ledingham JM; Laverty R
    Clin Exp Pharmacol Physiol; 2000 Aug; 27(8):642-6. PubMed ID: 10901398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enalapril attenuates cardiorenal damage in nitric-oxide-deficient spontaneously hypertensive rats.
    Pereira LM; Bezerra DG; Machado DL; Mandarim-de-Lacerda CA
    Clin Sci (Lond); 2004 Mar; 106(3):337-43. PubMed ID: 14629192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enalapril does not prevent the myocardial ischemia caused by the chronic inhibition of nitric oxide synthesis.
    Moreno H; Piovesan Nathan L; Pereira Costa SK; Metze K; Antunes E; Zatz R; De Nucci G
    Eur J Pharmacol; 1995 Dec; 287(1):93-6. PubMed ID: 8666033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiomyocyte volume-weighted nuclear volume and spironolactone therapy in spontaneously hypertensive rats.
    Mandarim-de-Lacerda CA; Madeira AC; Pereira LM
    Anal Quant Cytol Histol; 2002 Dec; 24(6):331-6. PubMed ID: 12508691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enalapril and quinapril improve endothelial vasodilator function and aortic eNOS gene expression in L-NAME-treated rats.
    De Gennaro Colonna V; Rossoni G; Rigamonti A; Bonomo S; Manfredi B; Berti F; Muller E
    Eur J Pharmacol; 2002 Aug; 450(1):61-6. PubMed ID: 12176110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.